Skip to content

Alkermes ALKS Return on equity

Return on equity at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
38.8%+7.3pp
Jazz Pharmaceuticals logo
Jazz PharmaceuticalsJAZZ
-9.1%-21.2pp
AbbVie logo
AbbVieABBV
89%+32.7pp
Axsome Therapeutics logo
Axsome TherapeuticsAXSM
-349.4%+109pp
Ionis Pharmaceuticals logo
Ionis PharmaceuticalsIONS
-67.6%-20.3pp
Neurocrine Biosciences logo
Neurocrine BiosciencesNBIX
22.5%+10.1pp

Other financials

Income statement

See full
Revenue$392.9M+28.2%
Gross profit$331.3M+28.8%
Operating income-$48.3M-450%
Net income-$66.5M-396%
EPS (diluted)-$0.40-408%

Balance sheet

See full
Cash & equivalents$351.6M-12.1%
Total debt$1.6B+2,034%
Total equity$1.8B+15.9%
Total assets$4.3B+105%

Cash flow

See full
Operating cash flow-$165.7M-268%
CapEx$4.1M-59.5%
Free cash flow-$169.8M-291%

Valuation

See full
Market cap$7.5B+9.7%
Enterprise value$8.73B+41.2%
P/E49.1×+29.7×
P/S4.8×+0.3×

Profitability

See full
Gross margin86.6%+2.2pp
Operating margin12.3%-13.6pp
Net margin9.8%-13.5pp
FCF margin14.2%-17.6pp

Returns & leverage

See full
Debt / equity0.9×+0.9×
Current ratio2.3×-1.1×

Where this comes from

Calculated from Alkermes’s reported figures.

Based on trailing twelve months.

The official record: Alkermes’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Alkermes's return on equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Alkermes's return on equity?
Alkermes (ALKS) reported return on equity of 9.4% in Q1 2026.
How has Alkermes's return on equity changed year-over-year?
Alkermes's return on equity decreased by 63.3% year-over-year, from 25.5% to 9.4%.
What is the long-term trend for Alkermes's return on equity?
Over 5 years (2020 to 2025), Alkermes's return on equity has grown at a 7.4% compound annual growth rate (CAGR), from -10.3% to 14.7%.
What does return on equity mean?
How much profit the company earns on the money shareholders have invested.
How do you interpret return on equity?
Higher is better, but very high ROE can be manufactured by leverage — a thin equity base inflates the ratio. Read it next to debt-to-equity and ROIC to tell genuine returns from balance-sheet engineering.
How does return on equity compare across companies?
Comparable across peers, with the leverage caveat. Negative or near-zero equity makes ROE meaningless, so it is suppressed there.